Wednesday, May 19, 2021

Microsoft to retire Internet Explorer on June 15, 2022

In a post on its official blog, Microsoft said that the Internet Explorer 11 desktop application will be retired and go out of support on June 15, 2022, for certain versions of Windows 10. 

This change will pave way for Microsoft Edge to provide a path to the web's future.

Wednesday, May 5, 2021

Health Canada authorizes use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age

Today, Health Canada authorized the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age. This is the first COVID-19 vaccine authorized in Canada for use in children and marks a significant milestone in Canada's fight against the COVID-19 pandemic.


Friday, April 23, 2021

Covid-19: Infections fell by 65% after first dose of AstraZeneca or Pfizer vaccine, data show

Infections of SARS-CoV-2 fell by 65% after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines, preliminary results from a large UK surveillance study indicate.

Reductions increased to 70% after a second dose of the Pfizer vaccine, data from the UK Covid-19 Infection Survey show. Not enough people had yet received two doses of the AstraZeneca vaccine to assess this.

Monday, April 19, 2021

Nasa successfully flies small helicopter on Mars

The drone, called Ingenuity, was airborne for less than a minute, but Nasa is celebrating what represents the first powered, controlled flight by an aircraft on another world.

https://www.bbc.com/news/science-environment-56799755

Thursday, April 15, 2021

Denmark continues vaccine rollout without the AstraZeneca vaccine

The National Board of Health paused the use of the COVID-19 vaccine from AstraZeneca on March 11, 2021. This was done on the basis of worrying signals from the ongoing safety monitoring of the COVID-19 vaccines. The vaccination program has since then continued with the vaccines from Pfizer / BioNTech and Moderna.


Sunday, April 11, 2021

Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer

What was a worrisome suspicion 4 weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterized by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million people who have received their first dose of the vaccine. More than 30 have died.

Tuesday, March 2, 2021

Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%

Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of its BBV152 (COVAXIN®). The whole virion inactivated COVID-19 vaccine candidate demonstrated an interim vaccine efficacy of 81% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research.